Three stories on Eph kinase inhibitors: From in silico discovery to in vivo validation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Three stories on Eph kinase inhibitors: From in silico discovery to in vivo validation

Published:2016-04 Issue: Volume:112 Page:347-366
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Unzue Andrea,Lafleur Karine,Zhao Hongtao,Zhou Ting,Dong Jing,Kolb Peter,Liebl Johanna,Zahler Stefan,Caflisch Amedeo,Nevado Cristina

Funder

Swiss National Science Foundation

Swiss Cancer League

Forschungskredit of the University of Zurich

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference97 articles.

1. The protein kinase complement of the human genome;Manning;Science,2002

2. Targeting cancer with small molecule kinase inhibitors;Zhang;Nat. Rev. Cancer,2009

3. Targeting protein kinases in central nervous system disorders;Chico;Nat. Rev. Drug Discov.,2009

4. Protein kinases – the major drug targets of the twenty-first century?;Cohen;Nat. Rev. Drug Discov.,2002

5. Kinase inhibitors for cardiovascular disease;Kumar;J. Mol. Cell Cardiol.,2007

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological Significance of EphB4 Expression in Cancer;Current Protein & Peptide Science;2024-03

2. In vivo stability of ²¹¹At-radiopharmaceuticals: on the impact of halogen bond formation;RSC Medicinal Chemistry;2024

3. Eph receptors and ephrins in cancer progression;Nature Reviews Cancer;2023-11-23

4. Targeting receptor tyrosine kinases in ovarian cancer: Genomic dysregulation, clinical evaluation of inhibitors, and potential for combinatorial therapies;Molecular Therapy - Oncolytics;2023-03

5. An investigation of binding interactions of tumor-targeted peptide conjugated polyphenols with the kinase domain of ephrin B4 and B2 receptors;Molecular Diversity;2023-02-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3